| Publication of Annual Report and Notice of AGM | 27-Oct-2025 | 08:13 | RNS |
| Preliminary Results for Year-end 30 June 2025 | 27-Oct-2025 | 07:00 | RNS |
| Further Major Advancement in Phalaborwa Test Work | 22-Sep-2025 | 07:00 | RNS |
| CIX Test Work shows Very High Purity Separation | 01-Sep-2025 | 07:00 | RNS |
| Issue of Shares to Directors under Incentive Plan | 04-Jul-2025 | 07:00 | RNS |
| Economic Assessment for Uberaba Project in Brazil | 17-Jun-2025 | 07:00 | RNS |
| Update on Laboratory Test Work in South Africa | 03-Jun-2025 | 07:00 | RNS |
| Interim Results for 6 Months to 31 December 2024 | 19-Mar-2025 | 07:00 | RNS |
| Interim Study confirms Phalaborwa viability | 16-Dec-2024 | 07:00 | RNS |
| Result of AGM | 07-Nov-2024 | 15:15 | RNS |
| Director/PDMR Shareholding | 06-Nov-2024 | 07:00 | RNS |
| Publication of Annual Report and Notice of AGM | 23-Oct-2024 | 09:00 | RNS |
| Preliminary Results for Year-end 30 June 2024 | 18-Oct-2024 | 07:00 | RNS |
| Completion of Ecora Royalty Transaction | 25-Sep-2024 | 07:00 | RNS |
| Phalaborwa Update | 18-Sep-2024 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 16.50p |
| Change Today | -2.50p |
| % Change | -13.16 % |
| 52 Week High | 24.50p |
| 52 Week Low | 9.10p |
| Volume | 7,630,886 |
| Shares Issued | 644.27m |
| Market Cap | £106.30m |
| RiskGrade | 751 |
| Value | ![]() |
|---|
| Price Trend | ![]() |
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
| Time | Volume / Share Price |
| 16:17 | 87,210 @ 16.10p |
| 14:05 | 380,000 @ 17.50p |
| 14:42 | 500,000 @ 17.00p |
| 09:18 | 500,000 @ 17.50p |
| 10:25 | 265,879 @ 16.93p |
You are here: research